The potential overvaluation of U.S. equities, largely driven by AI-bullish tech firms, has sparked fears of a dot-com-style ...

These rulings offer a faint glimmer of light at the end of a tunnel, yet executive overreach continues unchecked in the ...

The reinsurer set a payout ratio of 55% of net profit. Last year, the company’s dividend amounted to 46% of its net profit.

And its latest collection, En Équilibre, takes this ethos to new heights, carving equilibrium out of excess. These are jewels ...

Transaction valued at $250 million, with up to $14 million in future milestones – – BioCryst will focus on driving ORLADEYO ...

Unlike federal employees, contractors typically don’t receive backpay when the government reopens from a shutdown. Low-wage ...

People have been speculating about the strange positioning of Donald Trump and Elon Musk's hands at Charlie Kirk's memorial ...

There's nothing better than cozying up by the fire, drinking a warm cup of tea and escaping into a good book. But there’s ...

Bitcoin is extending its bull run, with projections pointing to $200,000 by December 2025. Analysts cite an ascending channel, a triple top, and an ascending ...

From the Comyn Ching Triangle to the MI6 building at Vauxhall Cross, Sir Terry Farrell's projects challenged modernist ...

Despite this, small and emerging biotech companies are the industry's main innovation engines. Industry data shows that over 80% of U.S. biopharmaceutical firms are small or emerging, and they develop ...